Three experts explain how obstructive sleep apnea, an often-ignored cardiovascular risk factor, may affect your heart and treatment options.
Sleep apnea can have untold consequences even in your waking hours. The good news? The condition is treatable.
IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results